
|Videos|July 26, 2022
Fezolinetant making waves for VMS
Author(s)Morgan Ebert, Managing Editor
Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Review finds no evidence linking prenatal paracetamol use to increased risk of autism, ADHD
2
FDA approves 5-year use for etonogestrel implant 68 mg contraceptive
3
LPCN 1154 for postpartum depression continues clinical process after safety review
4
Interim safety data of RSVpreF vaccination during pregnancy, with Ashley Michnick, PharmD, PhD
5











